Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 3,306 | 3,931 | 2,571 | 2,798 | 7,596 |
| Cost of Goods | 5,280 | 1,845 | 1,688 | 1,107 | 4,531 |
| Gross Profit | -1,974 | 2,085 | 883 | 1,691 | 3,065 |
| Operating Expenses | -380 | 5,147 | 2,031 | 1,695 | 4,196 |
| Operating Income | -1,314 | -2,216 | -460 | 103 | -512 |
| Interest Expense | 741 | 283 | 109 | 110 | 221 |
| Other Income | -318 | 0 | 0 | -7 | 55 |
| Pre-tax Income | -2,373 | -2,500 | -568 | -13 | -678 |
| Income Tax | N/A | N/A | N/A | N/A | -44 |
| Net Income Continuous | -2,376 | -2,500 | -568 | -13 | -634 |
| Net Income | $-2,376 | $-2,500 | $-568 | $-13 | $-632 |
| EPS Basic Total Ops | -0.72 | -0.48 | -0.12 | 0.00 | -0.26 |
| EPS Basic Continuous Ops | -0.69 | -0.44 | -0.16 | 0.00 | -0.19 |
| EPS Diluted Total Ops | -0.72 | -0.48 | -0.12 | 0.00 | -0.26 |
| EPS Diluted Continuous Ops | -0.69 | -0.44 | -0.16 | 0.00 | -0.19 |
| EBITDA(a) | $-994 | $-2,011 | $-376 | $186 | $-410 |